Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904

Journal of Clinical Oncology

Volumn 28, Issue 2, 2010, Pages 202-206

  Bogart, Jeffrey A ^a   Hodgson, Lydia ^a   Seagren, Stephen L ^a   Blackstock, A William ^a   Wang, Xiaofei ^a   Lenox, Robert ^a   Turrisi III, Andrew T ^a   Reilly, John ^a   Gajra, Ajeet ^a   Vokes, Everett E ^a   Green, Mark R ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANCER PAIN; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LUNG DISEASE; LUNG NON SMALL CELL CANCER; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; RADIATION DOSE; DISEASE FREE SURVIVAL; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; PHASE 1 CLINICAL TRIAL;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 74949112931     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.0753     Document Type: Article

References (21)

1. Mountain CF: A new international staging system for lung cancer. Chest 89:225S-233S, 1986 (suppl 4)
2. Bach PB, Cramer LD, Warren JL, et al: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198-1205, 1999
3. Kyasa MJ, Jazieh AR: Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer. South Med J 95:1149-1152, 2002
4. McGarry RC, Song G, des Rosiers P, et al: Observation-only management of early stage, medically inoperable lung cancer: Poor outcome. Chest 121:1155-1158, 2002
5. Timmerman RD, Paulus R, Galvin J, et al: Toxicity analysis of RTOG 0236 using stereotactic body radiation therapy to treat medically inoperable early stage lung cancer patients. Int J Radiat Oncol Biol Phys 69:S86, 2007 (suppl 3)
6. National Cancer Institute: Phase III randomized study of sublobar resection with versus without intraoperative brachytherapy in high-risk patients with stage I non-small cell lung cancer. http://www.cancer.gov/search/ ViewClinicalTrials.aspx?cdrid=422346&version=HealthProfessional& protocolsearchid=5691197
7. National Cancer Institute: Phase II pilot study of radiofrequency ablation in high-risk patients with stage IA non-small cell lung cancer. http://www.cancer.gov/ search/ViewClinicalTrials.aspx?cdrid=426417&version= HealthProfessional&protocolsearchid=5691200
8. Shennib H, Bogart J, Herndon JE, et al: Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: The Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg 129:813-818, 2005
9. Chen M, Hayman JA, Ten Haken RK, et al: Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: Is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys 64:120-126, 2006
10. Bradley J, Graham MV, Winter K, et al: Toxicity and outcome results of RTOG9311: A phase I-II dose escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 61:318-328, 2005
11. Fowler JF, Chappell R: Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys 46:516-517, 2000
12. Therasse P, Arbuck S, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205-216, 2000
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
14. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al: Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys Nov 75:677-682, 2009
15. Timmerman R, McGarry R, Yiannoutsos C, et al: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833-4839, 2006
16. Yang Y, Xing L: Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology. Med Phys 32:3666-3677, 2005
17. ClinicalTrials.gov: Radiation therapy in treating patients with stage I or stage II non-small cell lung cancer that cannot be removed by surgery. http:// clinicaltrials.gov/ct2/show/record/NCT00346320
18. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al: Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 70:685-692, 2008
19. Nagata Y, Takayama K, Matsuo Y, et al: Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63:1427-1431, 2005
20. Hof H, Muenter M, Oetzel D, et al: Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 110:148-155, 2007
21. Strauss GM, Herndon JE, Maddaus MA, et al: Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups J Clin Oncol 31:5043-5051, 2008